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ABSTRACT 
CodY is a branched-chain amino acid 
(BCAA) and GTP sensor, and a global regulator 
of transcription in low G + C Gram-positive 
bacteria. It controls the expression of over 100 
genes and operons, principally by repressing 
during growth genes whose products are required 
for adaptations to nutrient limitation. However, the 
mechanism by which BCAA binding regulates 
transcriptional changes is not clear. It is known 
that CodY consists of a GAF domain that binds 
BCAAs and a winged helix-turn-helix (wHTH) 
domain that binds to DNA, but the way in which 
these domains interact and the structural basis of 
the BCAA-dependence of this interaction are 
unknown. To gain new insights, we determined 
the crystal structure of unliganded CodY from 
Bacillus subtilis revealing a 10-turn D-helix 
linking otherwise discrete GAF and wHTH 
domains. The structure of CodY in complex with 
isoleucine revealed a reorganised GAF domain. In 
both complexes CodY was tetrameric. Size 
exclusion chromatography with multiangle laser 
light scattering (SEC-MALLS) experiments 
showed that CodY is a dimer at concentrations 
found in bacterial cells. Comparison of structures 
of dimers of unliganded CodY and CodY-Ile 
derived from the tetramers showed a splaying of 
the wHTH domains when Ile was bound; splaying 
is likely to account for the increased affinity of 
Ile-bound CodY for DNA. Electrophoretic 
mobility shift and SEC-MALLS analyses of CodY 
binding to 19-36 base-pair operator fragments are 
consistent with isoleucine-dependent binding of 
two CodY dimers per duplex. The implications of 
these observations for effector control of CodY 
activity are discussed. 
________________________________________ 
In low G+C Gram-positive bacteria, CodY 
is a global regulatory protein that controls the 
transcription of numerous genes. In Bacillus 
subtilis, the species in which it was first identified, 
CodY is a nutrient sensor that represses during 
growth genes that are turned on under conditions 
of nutrient limitation (1). The CodY regulon in 
this organism, encompassing more than 100 genes 
and operons, encodes degradative enzymes, 
transporter proteins, catabolic enzymes, antibiotic 
synthesis pathways, and factors involved in the 
development of genetic competence, and 
sporulation (2,3). In human pathogens, such as 
Staphylococcus aureus (4,5), Streptococcus 
pneumoniae (6), S. pyogenes (7), Listeria 
monocytogenes (8,9), B. anthracis (10), and 
Clostridium difficile (11), CodY also regulates 
virulence gene expression and provides a 
regulatory link between metabolism and 
pathogenesis (12). 
CodY from B. subtilis and most other low 
G+C Gram-positive bacteria is a DNA-binding 
protein that is activated by the branched-chain 
amino acids (BCAAs), leucine, isoleucine and 
valine, which may be viewed as signals of the 
metabolic status of the cell, and GTP, which may 
signal the energetic status of the cell (13,14). 
During growth in rich media, the concentrations of 
these species are high and CodY binds to 
numerous target promoters and represses 
transcription of many genes while activating 
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others (2). As the cells begin to experience 
nutrient limitation, the concentrations of BCAAs 
and GTP drop, leading to dissociation of CodY 
from the DNA and derepression of genes that are 
required for adaptation to nutrient-poor conditions. 
In the majority of cases, CodY is a repressor 
competing for DNA binding with RNA 
polymerase or with other positive regulators or 
causing premature termination of transcription by 
a roadblock mechanism (15). At some target 
genes, CodY acts as an activator either directly or 
indirectly (2,16,17). CodY binds to a 15-
nucleotide canonical consensus sequence 
AATTTTCWGAAAATT that was first identified 
for the protein from Lactococcus lactis (18,19), 
and later shown to play an important role in B. 
subtilis (20). 
The scope and complexity of CodY 
regulation of gene expression in B. subtilis have 
been revealed by genome-wide studies 
(2,3,21,22). These identified the substantial 
complement of CodY binding sites on the 
chromosome of B. subtilis and the broad range of 
affinities CodY has for these sites (22), consistent 
with the notion that the threshold concentration of 
CodY activity needed to trigger a transcriptional 
response varies from gene to gene. This gives rise 
to hierarchical control of gene expression in the 
CodY regulon allowing differential transcriptional 
responses according to the extent of nutrient 
limitation (3). 
CodY from B. subtilis consists of 259 
amino acid residues. The crystal structures of two 
fragments of CodY from B. subtilis that constitute 
its effector (residues 1-155) and DNA binding 
(residues 168-259) domains have been solved 
(23). CodY(1-155) is a dimer of GAF (cGMP-
stimulated phosphodiesterases, adenylate cyclases, 
FhlA (24)) domains. It consists of three tiers, a 
basal three-helix bundle which forms a 
dimerisation surface, a central five-stranded E-
sheet, and a distal region formed by two extended 
loops which connect adjacent strands on the sheet. 
In complexes with isoleucine or valine, these 
loops embrace the ligand; comparison with the 
uncomplexed GAF domain reveals up to 15 Å 
displacements of backbone atoms in these loops 
upon effector binding (25). The C-terminal 
fragment CodY(168-259) has a winged helix-turn-
helix (wHTH) domain fold. 
These structures provided insights into the 
mode of BCAA binding and a basis for 
interpreting sequence conservation in CodY 
orthologues, but they gave no insights into the 
juxtaposition of the domains in the intact molecule 
and thus it was not possible to infer how effector 
binding alters the structure of the protein so as to 
regulate DNA binding. Here, we describe the 
crystal structure of full length CodY in the 
unliganded state, together with that of a point 
mutant, CodY(L3S) in complex with isoleucine. 
These data, together with light scattering data on 
CodY and its complexes with DNA in solution, 
allow a mechanism for isoleucine control of DNA 
binding by CodY to be proposed. 
RESULTS 
Domain Organisation in CodY - The 
crystallisation and preliminary X-ray analysis of 
the full length CodY protein were reported 
previously (26). However, the crystals were not 
easy to reproduce and we were unable to solve 
their structure either by ab initio phasing or by 
molecular replacement using the coordinates for 
the isolated GAF domain in complex with 
isoleucine together with the coordinates for the 
wHTH domain (23). The structure of the 
unliganded form of the GAF domain (25) 
provided a search model that allowed successful 
structure solution by molecular replacement 
methods. 
We have solved the structure of unliganded 
CodY in three different crystal forms containing 
14 (Form A), 10 (Form B) and 2 (Form C) 
molecules in the asymmetric unit from data sets 
extending to 4.6 Å, 3.0 Å and 3.7 Å spacing, 
respectively (Table 1). These crystals were grown 
in the presence of different buffers, precipitants 
and additives as described in Materials and 
Methods. For two of the crystallisations, GTP or a 
GTP analogue was present though neither was 
observed bound to the protein. The following 
descriptions relate to the structure of the Form B 
crystals, since these crystals diffracted to the 
highest resolution (3.0 Å). In addition, we have 
solved the structure of a leucine3 to serine mutant, 
CodY(L3S), in complex with isoleucine at 3.0 Å 
resolution in a crystal form containing four 
molecules per asymmetric unit (Table 1). We have 
been unable to obtain crystals of either liganded 
wild-type CodY or unliganded CodY(L3S) 
suitable for X-ray analysis.  
The full-length CodY protomer has an 
elongated structure that spans 80 Å in the longest 
dimension with a dumb-bell shape (Fig. 1). The 12 
residues (156-167) that link the previously 
reported GAF and wHTH domain structures are in 
an D-helical conformation. They extend helix D5 
in the GAF domain and connect it to what was 
hitherto named helix D6 in the wHTH domain, 
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thereby creating a single D-helix spanning 
residues 137 ± 177. For the full-length CodY, the 
secondary structure elements are renumbered 
accordingly in Fig. 1C. The inter-domain linker 
portion of this helix has an unusual sequence with 
9 of the 12 residues in the 156-167 segment 
possessing ionisable side-chains including five 
glutamates in a string of six residues. Within the 
CodY chain, there are no non-covalent 
interactions between the domains that exist as 
discrete entities. As a result, the isoleucine-
binding site in the GAF domain and the helix-turn-
helix, which constitutes the DNA binding site in 
the wHTH domain, are remote from one another 
(Fig. 1A and B). 
The Branched-Chain Amino Acid Binding 
Pocket - Isoleucine was bound to the GAF 
domains of all four subunits in the CodY(L3S) 
tetramer. The ligand was almost completely 
enclosed in a pocket formed by the EE and 
EE segments of the polypeptide (Fig. 1B and 
C). This pocket is distal to the site of the Leucine-
3 to Serine substitution which resides in helix D1 
at the N-terminus. The ligand carboxylate forms 
an ion-pair with the side chain of Arg61 and a 
further polar contact with the main chain amide of 
Val100 while its amino group forms polar contacts 
to the main chain carbonyl groups of Thr96 and 
Phe98 (Fig. 1D). The isobutyl side chain of the 
isoleucine ligand projects into the protein parallel 
to the E-sheet and is surrounded by the side chains 
of Met62, Met65, Phe71, Pro72, Tyr75, and Pro99 
(Fig. 1B and D). Various amino acid substitutions 
at positions 61, 71 and 98 have been shown to 
have a range of effects on CodY activity (3,27-
29). This mode of isoleucine binding to 
CodY(L3S) exactly recapitulates that seen 
previously in the structure of isolated GAF 
domain of the native protein (23). When 
comparing chains from the CodY(1-155) and full 
length CodY(L3S) crystal structures, the average 
pairwise root mean squared deviation (rms') of 
equivalent CD atoms is 0.7 Å. We conclude that 
ligand binding is essentially unchanged in 
CodY(L3S) and that the effects of the leucine3 to 
serine mutation on the tertiary structure of the 
GAF domain are barely discernible. 
As may be seen in Fig. 1E, in the absence 
of ligand, the GAF domain structure in CodY is 
significantly altered in the vicinity of the ligand 
binding site. The positional rms' following least 
squares superposition of 154 equivalent GAF 
domain CD atoms is 3.4 Å. However, the 
structural changes are unevenly distributed (133 
CDsuperpose with an rms' = 1.2 Å) because 
very large deviations are seen in residues 94-108. 
Here, >10 Å atomic positional displacements are 
observed as the EEsegment undergoes 
dramatic rearrangement accompanying the binding 
and release of the ligand, so much so that the 
ligand-binding pocket is not formed in the absence 
of the ligand. Again, the unliganded GAF domain 
conformation seen in the full length protein 
resembles that seen in the crystal structure of 
unliganded CodY(1-155) with a positional rms' 
of 0.4 Å for equivalent CD atoms. As a result, the 
structural changes accompanying isoleucine 
binding to the full-length protein closely match 
those reported previously for ligand binding to the 
isolated GAF domain (25).  
Quaternary structure in the crystal - 
Examination of the molecular packing in the 
crystals of unliganded CodY reveals that the basic 
building block of all three crystals is a tetramer. 
The tetramer in the Form C crystals and one of the 
tetramers in both the Form A and the Form B 
crystals are generated by crystallographic 2-fold 
symmetry. Superposition of the eight tetramers 
from the three crystal forms suggests that they are 
essentially identical within the limits of the data. 
As before, the following description relates to a 
tetramer from the Form B crystals since these 
crystals diffracted to the highest resolution. 
The tetramer has approximate overall 
dimensions of 105 Å x 75 Å x 75 Å (Fig. 2). The 
GAF domains exist as two pairs of dimers 
flanking four wHTH domains. The latter are 
centrally located and tetrahedrally arranged. Each 
GAF domain dimer has a two-fold axis of 
symmetry running in the vertical direction in Fig. 
2. The GAF domain dimer is formed by 
interactions of helices D1 and D5 in subunits A 
and B in Fig. 2, creating an intermolecular helical 
bundle. Equivalent interactions are formed for 
subunits C and D. The central sections of the D5 
helices in each dimer extend in the vertical 
direction from the GAF domains to form 
interactions with the pair of wHTH domains 
pendant from the distal pair of CodY protomers. 
Finally, these helices then extend into the wHTH 
domain where residues 165-177 of all four chains 
contribute to a second intermolecular helical 
bundle. A local hydrophobic core is created by the 
packing of the side chains of Ala170, Val171 and 
Met174 from each of the four subunits. There is, 
in addition, the opportunity for polar interactions 
between the side chains of Lys169 and Gln173. A 
similar but not identical tetrahedral organisation of 
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four wHTH domains was observed in the crystal 
structure of CodY(168-259) determined 
previously (1b18) (23); these quaternary 
interactions were considered to be without 
physiological significance, in part because these 
domains possessed an artificial N-terminus (23). 
The domain topology of the isoleucine-
bound CodY(L3S) tetramer is superficially similar 
to that of the unliganded wild-type form, however 
the packing of the chains is significantly different 
(Fig. 2B). As shown in the right hand panels of 
Fig. 2, the lateral protrusion of the wHTH domains 
is more striking in the liganded form. This results 
from changes in the relative orientations of the 
long interdomain helices, as discussed later. For 
both the liganded and unliganded CodY tetramers, 
while the wing elements of the wHTH are on the 
outside of the assembly, the so-called recognition 
helices of the HTH (D8) are nearer the centre of 
the tetramer and residues from the turn connecting 
the two helices of the HTH are in close proximity 
to the GAF domains of the distal subunits. As a 
result, in both the unliganded CodY and 
isoleucine-bound CodY(L3S) tetramers, DNA is 
sterically hindered from binding to the wHTH 
domains (Fig. 2C). 
SEC-MALLS Reveals a CodY Dimer - 
Since CodY is thought to be a dimer (23,25), the 
observation of tetramers in the crystals was 
unexpected even though earlier gel-filtration data 
had shown evidence for a possible dimer-tetramer 
equilibrium (26). We therefore re-investigated the 
quaternary structure of CodY by performing a size 
exclusion chromatography and multi-angle laser 
light scattering (SEC-MALLS) analysis. In these 
experiments, CodY (1 mg.ml-1) samples were 
incubated in the presence and absence of 
isoleucine (10 mM), and passed down a Superdex 
S200 column. As the material eluted from the 
column, the refractive index was recorded to give 
a measure of protein concentration and the light 
scattering was recorded to allow calculation of the 
molar mass. As shown in Fig. 3A, CodY elutes as 
a single symmetric peak in these experiments and 
the molecular weight calculations reveal a stable 
species of mass 58 kDa. CodY has 259 amino acid 
residues and a calculated mass of 29 kDa and we 
conclude that the protein is dimeric under these 
solution conditions. The inclusion of isoleucine in 
the column chromatography buffer had no effect 
on the trace. These experiments show that CodY is 
a dimer at a concentration of 1 mg.ml-1 (~ 35 PM) 
in solution. In contrast, at the 10 to 20-fold higher 
CodY concentrations used for crystallisation, 
CodY is evidently able to form tetramers. The 
intracellular concentration of CodY would be ~3 
PM if we make a generous estimate of 10,000 
CodY protomers per B. subtilis cell (30). We 
conclude that CodY is a dimer under physiological 
conditions. 
CodY(L3S) is predominantly monomeric -
These SEC-MALLS experiments were repeated 
for the CodY(L3S) mutant.  The profiles revealed 
a lower molecular weight species of ~ 34 kDa 
indicating that this protein is predominantly 
monomeric (Fig. 3A). Leu3 is situated in the 
interface between the GAF domains in the 
tetrameric assembly where it forms interactions 
with the side chains of Leu3 and Ile141 in the 
partner subunit that contribute to a local 
intermolecular hydrophobic core (Fig. 3B). 
Substitution of the Leu3 residues with smaller and 
polar serines would be expected to destabilise this 
interface. However, at higher protein 
concentrations, it is evident that CodY(L3S) 
assembles to form dimers as well as the tetramers 
that are observed in the crystals. 
CodY(L3S) is functional in vivo - As the 
Leucine3 to Serine substitution is present in the 
crystals of the CodY-isoleucine complex and since 
this mutation affects the stability of CodY dimers, 
we constructed a B. subtilis strain harbouring a 
version of codY encoding the L3S mutation. The 
codY(L3S) mutant was introduced into B. subtilis 
strains that harbour at the amyE locus a 
transcriptional lacZ fusion to the promoters for 
either ybgE or bcaP (15,31). PbcaP and PybgE are 
known to be regulated by CodY in wild type B. 
subtilis (15,29). E-galactosidase activity was 
measured in the codY(L3S) strain and in otherwise 
isogenic wild type codY and codY null mutant 
strains. In a defined medium in which CodY is 
maximally active, E-galactosidase activity 
dependent on the PbcaP and PybgE promoters in the 
codY(L3S) strain was 100-fold and 20-fold higher, 
respectively, than in the wild-type strain (Table 2). 
However, the level of E-galactosidase activity in 
the codY(L3S) strain remained 10-fold and 20-fold 
lower, respectively, than that in the codY null 
mutant strain (Table 2). This suggests that 
CodY(L3S) retains the capacity to bind to DNA 
and repress transcription in vivo, even though its 
activity is considerably lower than that of the 
native CodY; as a result, there is significant 
derepression of transcription of the target genes. 
This result suggests that weakening of the dimer-
forming interactions between the GAF domains 
lowers CodY activity consistent with the notion 
that CodY functions as a dimer in B. subtilis cells. 
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The CodY Dimer is Most Likely Formed 
through GAF-GAF domain Interactions - The 
observation of dimers of wild type CodY in the 
SEC-MALLS experiment prompted us to 
consider which of the pairs of chains in the 
tetramer observed in the crystal constitute the 
dimer observed in solution. There are three 
possibilities as illustrated in Fig. 3C - AB 
(equivalent to CD), AC (equivalent to BD) and 
AD (equivalent to BC). The interfacial areas in 
the three possible dimers are 830 Å2 (AB), 720 
Å2 (AC) and 1300 Å2 (AD) in the unliganded 
protein and 830 Å2 (AB), 130 Å2 (AC) and 1,410 
Å2 (AD) in the CodY(L3S) isoleucine complex. 
We favour the AB dimer for three reasons. 
Firstly, the AB dimer preserves the interface 
observed in the structure of the isolated GAF 
domain dimer and the residues of this interface 
are well-conserved among CodY orthologues 
(23). Moreover, much of the surface of the 
protein that contributes to this interface is 
hydrophobic. Thus the exposure of this surface in 
the AC and AD dimers would be expected to be 
energetically unfavourable. Secondly, the L3S 
mutation, which disrupts CodY dimer formation, 
maps to the GAF-GAF interface which is unique 
to the AB dimer. Finally, simple modelling 
shows that the wHTH elements in the AB dimer 
would be able to bind to DNA in a conventional 
manner. In contrast, the AC and AD dimers 
would be severely sterically hindered from doing 
so by the presence of the distal GAF domains. 
We conclude that the AB dimer is most likely to 
be the form observed in solution by SEC-MALS. 
Structural Changes Accompanying Ligand 
Binding - As previously stated, we were unable to 
obtain crystals of liganded wild-type CodY or 
unliganded CodY(L3S). Therefore, to explore the 
basis of branched-chain amino acid regulation of 
DNA binding, we compared the three-
dimensional structures of the unliganded wild-
type CodY and liganded CodY(L3S) forms, 
mindful of the caveats associated with the L3S 
mutation.  
Thus the unliganded CodY and liganded 
CodY(L3S) dimers were superposed by least 
squares minimisation procedures applied to the 
positions of the backbone CD atoms of the GAF 
domains from the AB dimers (Fig. 4). This gives a 
positional rms' of 3.5 Å for 304 equivalent CD 
atoms. However, 270 of these CD atom pairs can 
be superposed with an rms' of 1.3 Å, emphasising 
that very large structural changes in the GAF 
domains are localised to the site of isoleucine 
binding (Fig. 4A). Following this superposition, it 
is apparent that isoleucine binding to CodY(L3S) 
is associated with displacements in the long D 
helix and a significant separation of the two 
wHTH domains in the dimer (Fig. 4). This results 
from changes in the directions of the interdomain 
helices Das they emerge from the GAF domains 
(Fig. 4B). The structural changes can be described 
as a combination of bending and twisting motions 
(Fig. 4A). In the dimer, the structural changes in 
each subunit lead to a significant splaying of the 
two helices and a noticeable separation of the 
wHTH domains. wHTH domains typically bind to 
DNA by aligning their recognition helices with the 
major groove of the DNA, with their wing 
elements forming contacts with the ribose-
phosphate backbone and in some instances 
extending into the adjacent minor groove. Dimeric 
wHTH domain-containing DNA binding proteins 
often bind to recognition sequences with elements 
of two-fold symmetry, often referred to as 
palindromic, that match the two-fold symmetry of 
the protein itself. The distance of separation of the 
wHTH domains is an important determinant of 
DNA binding, so that the alteration in the 
juxtaposition of the DNA binding domains of 
CodY upon ligand binding would be expected to 
change the ability of CodY to bind to DNA. At the 
resolution of the structures determined here, 
however, it is difficult to discern how changes in 
the GAF domain upon ligand binding lead to 
changes in helix D5 and the relative arrangement 
of the wHTH domains.  
DNA Binding - A 15 nucleotide consensus 
sequence AATTTTCWGAAAATT (where W = A 
or T) that was first identified for the CodY protein 
from Lactococcus lactis (18) (19) has been shown 
to play a crucial role in B. subtilis CodY function 
(20). To provide reagents for co-crystallisation of 
CodY with DNA and to further analyze CodY 
binding, short oligonucleotide duplexes of 19, 31 
or 36 bp were designed based on the upstream 
CodY-binding motif of the bcaP promoter (31). 
The 19, 31 and 36 bp constructs consist of the 15 
bp consensus motif with two downstream bp and 
2, 14 or 19 upstream bp, respectively (Table 3). In 
each case, three nucleotide substitutions (the p8 
mutation; underlined) (31) were introduced into 
the CodY-binding motif to generate a perfect 
consensus sequence. Although crystals containing 
both DNA and protein were obtained from 
crystallisation experiments set up with mixtures of 
CodY and the BcaPp8(36) duplex, these did not 
diffract.  
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In electrophoretic mobility shift assays, 
wild-type CodY in the presence of a mixture of 
isoleucine, leucine and valine (ILV) was able to 
bind the BcaPp8(19) duplex, indicating that this 
short sequence is sufficient for protein-DNA 
interaction (Fig. 5A). Binding of wild-type CodY 
to the BcaPp8(31) or BcaPp8(36) duplexes was 
even more efficient, with an apparent Kd of 1.6 
nM (Fig. 5C and E). The affinity of CodY for the 
longer duplexes is almost identical to its affinity 
for the extended 235-bp bcaPp8 fragment (1 nM) 
(31), indicating that the 31-bp duplex contains all 
the determinants important for binding. 
Interestingly, CodY formed only one type of 
complex (C1) with the BcaPp8(19) duplex; 
however, an additional, lower mobility complex 
(C2) was the predominant form in the presence of 
the BcaPp8(31) or BcaPp8(36) duplexes (Fig. 5A, 
C and E). The two complexes are likely to 
represent species with different CodY binding 
stoichiometries, BcaPp8(19) is presumably bound 
by one CodY dimer whereas BcaPp8(31) and 
BcaPp8(36) are each bound by two CodY dimers. 
In the absence of ILV, CodY formed complexes 
with DNA with considerably lower affinity (Fig. 
5B, D and F). The loss of affinity was very 
dramatic in the case of the BcaPp8(19) duplex. No 
higher-mobility complex was observed with the 
longer duplexes, suggesting impaired stability of 
this complex in the absence of ILV (Fig. 5D and 
F). 
Binding of CodY(L3S) to the BcaPp8(19) 
and BcaPp8(36) duplexes was less efficient than 
that of the wild-type CodY, consistent with the 
lower activity of the mutant protein in vivo (Fig. 
6). CodY(L3S) bound very weakly to the 
BcaPp8(19) duplex even in the presence of ILV 
(Fig. 6A and B). Moreover, it did not form the 
higher mobility complex with the BcaPp8(36) 
duplex (Fig. 6C and D). The weak capacity of 
CodY(L3S) to form the higher mobility complex 
is consistent with its defect in dimer formation in 
solution. However, CodY(L3S) dimers are 
apparently stabilized if two of them are allowed to 
interact together, as revealed by the relatively 
efficient formation of the lower mobility complex 
with the BcaPp8(36) duplex.  
The interaction of CodY with the 
BcaPp8(36) duplex DNA was further examined 
using SEC-MALLS. As shown in Fig. 7, the DNA 
duplex eluted as a single symmetrical peak from 
the Superdex S200 column with an Mr value 
calculated from the light scattering data of 23 kDa. 
This is consistent with its molar mass of 22 kDa. 
Similarly, in the absence of DNA, the 
experimentally derived Mw of CodY is 58 kDa, 
consistent with a dimer. In the two subsequent 
experiments, CodY was incubated with 
BcaPp8(36) in the presence and absence of 10 mM 
isoleucine. In the absence of isoleucine, we 
observed a somewhat asymmetric peak in the 
differential refractive index profile centred at 28 
mins (Fig. 7B), a lower retention time than that of 
CodY alone. The molar mass associated with this 
species is ~70 kDa. In contrast, the presence of 
isoleucine caused a significant reduction in the 
retention time of the principal species present and 
a significant rise in its molecular mass to ~130 
kDa. We interpret the 130 kDa species to be a 
complex formed between four molecules of CodY 
and one BcaPp8(36) duplex (138 kDa). We 
observed a similar ~130 kDa species when 
analysing a mixture of CodY and a 32 base pair 
duplex derived from the CodY-regulated yurP 
(frlB) promoter (20) in the presence of isoleucine 
but not in its absence (data not shown).  
The 70 kDa species observed in the 
absence of isoleucine has a higher mass than that 
expected for a CodY dimer (58 kDa) but lower 
than that expected for a dimer of CodY bound to 
one BcaPp8(36) duplex (81 kDa). It can be seen 
that the peak on the chromatogram for this 
complex overlaps with the leading edge of the 
peak for the free DNA trace. The presence of the 
uncomplexed DNA would lower the weight 
average molecular weight of the eluting species 
calculated by MALLS, consistent with the 
presence of a higher molecular weight protein-
DNA complex such as CodY2-BcaPp8(36). The 
EMSA experiments suggest however that this 
species would not be observed and it is more 
likely that the profile reflects the extensive 
dissociation of CodY4-BcaPp8(36) complexes 
accompanying chromatography in the absence of 
Ile.  
These results confirm that the C1 
species observed in the EMSA experiments 
represent CodY2 complexes with DNA and that 
the lower mobility C2 species are complexes of 
CodY4 and BcaPp8(31) or BcaPp8(36), 
implying the presence of two CodY2 binding 
subsites on these longer duplexes. Therefore, 
one might expect that inactivation of one of the 
subsites within such a DNA duplex would 
reduce binding of one of the CodY dimers 
resulting in the formation of a DNA complex 
containing only one CodY dimer. Indeed, when 
ZHLQWURGXFHGPXOWLSOHPXWDWLRQVLQWKH¶SDUW
of the BcaPp8(31) duplex by creating its p18 
version (Table 3), we observed a significant 
Structure of Global Regulator CodY 
 
7 
 
reduction of C2 complex formation and the 
emergence of C1 as the predominant complex 
with CodY (Fig. 5G). 
 
DISCUSSION 
CodY is a Dimer which Binds 
Cooperatively to bcaP DNA - The structures of 
full length CodY from B. subtilis determined 
here reveal the effector binding domain and the 
DNA binding domain as discrete entities 
separated by a helical linker. In the crystals, four 
CodY protomers are assembled into an unusual 
tetramer in which four wHTH domains are 
sandwiched between two GAF domain dimers. 
For the unliganded form in particular, the 
tetramer is compact with extensive subunit 
interfaces. From within this tetramer structure, 
there is no possibility that the wHTH domains of 
CodY could bind to DNA in a conventional 
manner, because the GAF domains of partner 
subunits in the tetramer occupy a substantial 
volume that would be taken up by the DNA 
duplex. (Fig. 2C). We considered therefore that 
this tetrameric form might represent an inactive 
state of CodY that prevails in the absence of 
nutritional signals. However, we found no 
evidence for CodY tetramers in SEC-MALLS 
experiments, which conclusively showed that 
CodY is a dimer even at protein concentrations 
higher than those found in vivo (Fig. 3A). 
Furthermore, unliganded CodY can bind to 
DNA, albeit with lower affinity than the BCAA-
liganded protein (Fig. 5). Thus, there is no 
evidence to suggest that the CodY tetramers 
observed here by crystallography are 
physiologically relevant. There are many cases 
where plausible, stable interfaces between 
molecules in crystals prove to have no functional 
significance, including examples from studies of 
proteins involved in gene regulation in Bacillus 
(32) (33).  
An interesting and important finding 
from this work is the establishment that CodY 
forms alternate complexes with short DNA 
fragments derived from the bcaP promoter. With 
the shorter 19 bp duplex, CodY forms a single 
complex. With the 31 bp and 36 bp duplexes, it 
forms two complexes as shown schematically in 
Fig. 8A. The first, C1, has a mobility similar to 
that of the complex formed with the 19-mer, 
while the second, predominant complex, C2, has 
lower electrophoretic mobility consistent with a 
larger size (Fig. 5). SEC-MALLS analysis of 
CodY mixed with BcaPp8(36) in the presence of 
isoleucine showed the formation of a complex 
consistent with four CodY protomers bound to a 
single duplex (Fig. 7). Collectively, our data 
suggest that C1 is CodY2-BcaPp8 with one 
CodY dimer bound per duplex and that C2 is 
CodY4-BcaPp8 with two dimers per duplex.  
Interestingly, in the absence of branched chain 
amino acids, the C1 complex appears to be much 
less stable for BcaPp8(19) and is not discernible 
at all for BcaPp8(31) or BcaPp8(36) (Fig. 5D). 
These data are consistent with cooperative 
binding of CodY to the longer duplexes with the 
affinity of the second dimer for the DNA 
augmented by the binding of the first dimer. 
Cooperativity, exhibited in the presence and the 
absence of ILV, may arise because the binding 
of the first CodY dimer to the DNA induces a 
conformational change in the duplex such that 
the second dimer can bind more readily. In this 
regard, the bcaP promoter fragments used here 
have a high bending propensity (34). 
Alternatively, the binding of the first dimer may 
help in the recruitment of the second dimer by 
contributing protein-protein interactions to 
supplement the protein-DNA interactions (Fig. 
8A). In the case of CodY, these interdimer 
interactions may be contributed either by the 
GAF domains or, as shown schematically in Fig. 
8A, by the wHTH domains. 
The exact role of protein-protein 
interactions in binding of two dimers and the 
precise contribution of each of the two subsites 
(Fig. 8A) to CodY binding remain unknown. It is 
also not known whether all CodY-binding sites 
are composed of two (or more) subsites; the exact 
stoichiometry of CodY binding to all CodY-
binding sites may be not identical. 
 
Structural Implications for DNA 
Binding - Comparisons of the structures of 
unliganded CodY and effector-bound 
CodY(L3S) reveal striking differences in the 
relative positions of the wHTH domains (Fig. 4). 
These differences could reflect the effect of Ile 
binding on CodY conformation which would 
lead us to conclude that the splayed 
conformation of CodY is more conducive to 
DNA binding, since Ile-bound CodY has a 
higher affinity for all bona fide binding sites 
tested to date. This conclusion relies, however, 
on the assumption that the mode of DNA 
binding is same for CodY(L3S) and wild type 
CodY bound to Ile. 
To assess the implications of the CodY 
structures for DNA binding, we analysed other 
homodimeric wHTH domain-containing 
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transcription factors (TFs) whose structures have 
been solved in complex with DNA. The most 
closely similar such structure is of the quinone 
sensing response regulator QsrR from S. aureus  
whose subunits can be overlaid on the wHTH 
domain of CodY with an rms' of 2.9 Å for 85 
aligned residues giving a Z-score of 4.1 (35). In 
the complex of QsrR with a 17 bp duplex, the 
respective recognition helices bind in 
consecutive major grooves of the DNA. These 
D-helices are related by a 28 Å translation and a 
70° rotation (Fig. 9A). Binding to the operator 
DNA in this system is reversed upon covalent 
attachment of menadione to Cys5 of QsrR, 
which leads to a 10° rotation and 9 Å separation 
of the subunits (35). Another structurally well-
characterised example is FadR of E. coli which 
regulates genes encoding enzymes of fatty acid 
metabolism. In the structure of its complex with 
a 19 bp fadB operator DNA, the two recognition 
helices of the wHTH domains are closely 
abutting (their helix axes can be superposed 
following a 9 Å translation and a 30° rotation) in 
the major groove of the DNA giving rise to a 
compact protein DNA complex (Fig. 9B). 
Binding of the effector, myristoyl-CoA, to the 
N-terminal domain leads to separation of the 
recognition helices by a further 7 Å, loss of 
DNA binding, and relief of repression (36). In 
IscR, which regulates genes involved in iron-
sulphur cluster biogenesis, longer DNA 
recognition sequences spanning 26 to 29 bp 
were used in crystallisation (37) (38) (Fig. 9C). 
In these complexes, the wHTH domains are 
separated by long C-terminal helices which 
mediate dimer formation such that the 
recognition helices of the wHTH in the 
respective subunits are related by a displacement 
of 36 Å and a 71° rotation. In this system, the 
iron-sulphur cluster effector binds within the 
wHTH itself so as to change the promoter 
specificity of the repressor. 
To facilitate comparison, we 
superimposed the wHTH domains of one of the 
chains (chain A) of unliganded CodY and Ile-
bound CodY(L3S) onto one of the 
corresponding domains of QsrR, FadR and IscR 
in their DNA complexes and observed the 
juxtaposition of the recognition helix in the 
partner wHTH domains and the DNA (Fig. 9D). 
This simple modelling suggests that the 
unliganded CodY dimer, in which the 
recognition helices from each chain are related 
by a 25 Å translation and a 40° rotation, could 
bind to a DNA duplex of ~20 bp. For the Ile-
bound CodY(L3S) structure, where splaying 
increases the translational and rotational 
separation of the recognition helices to 34 Å and 
45°, a longer DNA recognition sequence of ~30 
base pairs would be needed.  
This analysis indicates that 19 bp is just 
sufficient to bind a CodY dimer in the more 
compact conformation we observe in the 
unliganded CodY crystals. Meanwhile, a pair of 
CodY dimers in the splayed conformation could 
bind to the 31-mer (BcaPp8(31)) and 36-mer 
(BcaPp8(36)) DNA duplexes only if the binding 
sites for each dimer are significantly overlapping 
as depicted in Fig. 8A and modelled in Fig. 8C. 
Such a mode of binding has been proposed 
previously (39). However, the modelling 
predicts that the splayed CodY dimer would be 
unable to bind to the 19-mer, BcaPp8(19). This 
is consistent with the poor ability of CodY(L3S) 
to bind the BcaPp8(19) duplex, but contrary to 
the experimental data obtained with the wild-
type CodY. One explanation for this is that the 
splayed conformation of CodY obtained with 
CodY(L3S) is specific to the mutant form of the 
protein. Alternatively, the CodY dimer may be 
able to engage the 19-mer duplex using just a 
single wHTH domain. 
Concluding remarks -  Crystals of CodY 
grew irreproducibly perhaps due to inherent 
flexibility in the CodY dimer, arising from 
relative motions of the wHTH domains relative 
to each other and the GAF domains. At low 
frequency, tetramers are evidently assembled in 
ZKLFKWKHVHGRPDLQPRWLRQVDUHµIUR]HQRXW¶E\
dimer-dimer interactions and this overcomes the 
barrier to lattice formation. A precedent for this 
is calmodulin, where early structures revealed 
independent calcium binding domains connected 
by a long D-helix in a dumb-bell arrangement 
(40). Later structures of calmodulin-target 
protein complexes showed altered 
conformations of the linker region and a 
spectrum of more compact relative domain 
arrangements (41) (42). 
The helical conformation of residues 
155-168, which link the two domains in CodY, 
is evidently stabilised by quaternary interactions 
with the distal pair of wHTH domains in the 
tetramers within the crystal. In the absence of 
these stabilising interactions, these residues 
could take up a different conformation or range 
of conformations. In this regard, the string of 
five glutamate side chains in six residues (160-
165, Fig. 1) in adjacent linker regions in the 
dimer would be expected to destabilise 
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electrostatically the compact helical 
conformation in this region of the subunit, 
possibly giving rise to a more extended 
conformation in solution. Interestingly, it has 
been shown for some promoters that the extent 
of CodY binding to DNA and CodY activation 
by isoleucine is pH-dependent (39). This 
behaviour may be associated with the titration of 
one or more of these glutamates. Regardless, this 
flexibility could allow the wHTH domains to be 
brought into contact with the GAF domains 
within the dimer so that they are able to sense 
directly the conformational changes brought 
about by BCAA binding as shown schematically 
in Fig. 8B. This would provide a basis for 
explaining the puzzling absence in the crystal 
structures of an obvious route for transducing 
the substantial structural changes upon ligand 
binding to the GAF domain, into structural 
alterations of the wHTH domains. A rigorous 
elucidation of the structural basis of (i) effector 
control of CodY activity and (ii) CodY-
recognition of the 15-bp consensus DNA 
binding motif, with its considerable degeneracy 
but clear two-fold symmetry, awaits the 
determination of structures of CodY-DNA 
complexes. 
While this manuscript was under 
review, crystal structures of CodY from B. 
cereus (BcCodY) and S. aureus (SaCodY) were 
reported (43). The domain arrangement in these 
orthologous proteins is similar to that observed 
in CodY from B. subtilis and tetramers similar to 
those reported here were observed for BcCodY. 
Curiously, the BCAA binding site in unliganded 
BcCodY resembles that of the liganded CodY 
from B. subtilis. Most interestingly, the SaCodY 
structure contains GTP which is bound at the 
junction of the long helix and the GAF domain 
in a dimeric form of the protein. The authors 
combine their structures to propose a model in 
which tetramers represent a physiologically 
inactive state of CodY. This model is yet to be 
rigorously tested and is unlikely to apply to 
CodY from B. subtilis which is clearly dimeric 
under conditions found in the cell. 
 
EXPERIMENTAL PROCEDURES 
 Bacterial strains and culture media -The 
B. subtilis strains used in this study are described 
in the text and were all derivatives of strain SMY 
(44) and grown at 37oC in TSS - 0.5% glucose - 
0.2% NH4Cl minimal medium supplemented 
with a mixture of 16 amino acids (45,46). The 
mixture contained all of the amino acids 
commonly found in proteins except for 
glutamine, asparagine, histidine, and tyrosine; the 
concentrations of isoleucine, leucine, and valine 
were 200 µg/ml each. DS nutrient broth medium 
with addition of agar was used for growth of 
bacteria on plates(46). Escherichia coli strain 
JM107 (47) was used for isolation of plasmids 
and was grown in L broth or on L agar plates 
(48). The following antibiotics were used when 
appropriate: tetracycline, 15 µg/ml; 
spectinomycin, 50 µg/ml; or the combination of 
erythromycin, 0.5 µg/ml, and lincomycin, 12.5 
µg/ml, for B. subtilis strains; ampicillin, 50 
µg/ml, for E. coli strains. 
DNA manipulations - Methods for 
general DNA manipulation, transformation, DNA 
sequencing, gel shift assays, and sequence 
analysis were as previously described (20,49). 
Oligonucleotides used in this work are described 
in Table 2. Chromosomal DNA of B. subtilis 
strain SMY or plasmid DNA was used as 
template for PCR as appropriate. All cloned 
PCR-generated fragments were verified by 
sequencing. 
CodY expression and purification - CodY 
was initially produced using the pBAD30 (50) 
derivative plasmid, pKT1(26), encoding residues 
Ala2-His259 of CodY with a C-terminal 
pentahistidine tag, with the protein purified as 
described previously(26). This protein was also 
used for the EMSA studies together with 
CodY(L3S)-His5 produced using the plasmid 
pBB1737, which was created by cloning the PCR 
fragment, synthesized using oligonucleotides 
oBB569 and oRPS33, into pBAD30 as described 
previously(27). 
Two other constructs were used to 
overproduce CodY for the structural studies 
described in this work. In an attempt to obtain 
better diffracting crystals, we switched the 
polyhistidine tag to the N-terminus so that it could 
be cleaved off after the affinity purification step. 
This second construct was generated by 
amplifying the CodY coding sequence of 
pBAD30-CodY using the primers CodYF1 and 
CodYR1 and capturing the NdeI /BamHI fragment 
in similarly cut pET28a(+). In addition to adding a 
purification tag to the encoded protein, the 
forward oligonucleotide introduced a Leucine 
codon in place of a Serine codon at position 3, 
whilst creating an NdeI site that facilitated 
cloning. The recombinant plasmid was introduced 
into E. coli BL21(DE3) for protein production. 
Cells were shaken in 0.5 l autoinduction medium 
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for 24 hours at 30°C before harvesting by 
centrifugation, resuspension in 20 mM sodium 
phosphate buffer pH 7.5, 0.5 M NaCl, 30 mM 
imidazole (Buffer A) supplemented with 1 mM 4-
(2-aminoethyl) benzene sulphonyl fluoride 
(AEBSF) and lysis by sonication. Following 
clarification by centrifugation, the supernatant was 
loaded onto a 1 ml HisTrap HP column that had 
been pre-charged with Ni2+ ions and equilibrated 
in Buffer A. The column was washed extensively 
with Buffer A and developed with a 30 mM ± 0.5 
M linear imidazole gradient in Buffer A. After the 
nickel chelation chromatography step, the protein 
was exchanged into 20 mM Tris-HCl buffer pH 
7.5 with 50 mM NaCl and treated overnight with 1 
unit/mg thrombin (BD Biosciences) to remove the 
polyhistidine tag and generate CodY protein with 
a residual tripeptide tag (GlySerHis) at the amino 
terminus and a Leucine 3 to Serine substitution. 
This CodY(L3S) protein was further purified by 
gel filtration chromatography on a Superdex S200 
16/60 column. 
A third construct was generated to direct 
the production of CodY, without the Leucine-3 
substitution and with an N-terminal human 
rhinovirus 3C protease cleavable polyhisitdine tag. 
Following polymerase chain reaction using the 
primers oVLC01 and oVLC02 (Table 4) and the 
pBAD30-CodY template, the amplified DNA was 
inserted into the vector pET-YSBLIC3C using 
ligation independent cloning methods (51), and E. 
coli NovaBlue cells harbouring a suitable 
recombinant plasmid were identified among 
kanamycin-resistant transformants. Following 
sequencing to confirm its authenticity, pET-
YSBLIC-BsCodY was introduced in E. coli 
BL21(DE3) for protein production. The 
recombinant protein was purified as described 
above except that the polyhistidine tag was 
removed by overnight cleavage with human 
rhinovirus 3C protease. A second nickel column 
was run to separate the cleaved protein from the 
uncleaved protein and the cleaved tag. The flow-
through fraction was collected, buffer exchanged 
into 20 mM Tris-HCl, 100 mM NaCl, and loaded 
onto a heparin column which was developed in 
this buffer over a 100-500 mM NaCl. 
The protein was then fractionated by gel filtration 
on a Superdex 200 column and concentrated by 
centrifugal membrane filtration using a 10 kDa 
molecular weight cutoff membrane filter 
(AminconR), to yield CodY with an N-terminal 
Gly-Pro-Ala tag in 20 mM Tris-HCl, 100 mM 
NaCl. 
Crystallisation - Form A crystals of 
unliganded CodY were grown in hanging drops 
formed by mixing 1 Pl of 10-20 mg.ml-1 CodY 
with 1 Pl of well solution containing 1 M sodium 
citrate pH 6.0 and 5 % glycerol. Form B crystals 
were similarly prepared by mixing 1 Pl of 10-20 
mg.ml-1 CodY containing 10 mM GTP with 1 Pl 
of well solution containing 0.1 M sodium citrate 
pH 5.6, 1.7 M lithium sulphate and 3 % dioxane. 
Finally, the Form C crystals were prepared by 
mixing 1 Pl of 10-20 mg.ml-1 CodY containing 5 
mM GTP-J-S and 2 mM Tris(2-
carboxyethyl)phosphine (TCEP) with 1 Pl of well 
solution containing 0.1 M sodium citrate pH 5.6, 
20 mM Tris-HCl pH 7.5, 35 % ammonium 
sulphate. 
Crystals of CodY(L3S) in complex with 
isoleucine were grown in hanging drops prepared 
by mixing equal volumes of 18 mg.ml-1 protein 
containing 20 mM isoleucine with a well solution 
which contained 15 % polyethylene glycol 5000, 5 
% tacsimate in 0.1 M HEPES buffer pH7.5.  
Data Collection, Structure Solution and 
Refinement - After transfer to solutions of mother 
liquor containing a suitable cryoprotectant, a 
preliminary X-ray analysis of crystals of CodY 
was carried out in-house using KD radiation from 
a copper rotating anode. Diffraction was initially 
very weak, but the quality of the diffraction data 
was significantly improved following cycles of 
crystal reannealing, that is, by repeated thawing in 
cryoprotectant and cryo-cooling of the crystals. 
Full three-dimensional data were collected from 
the strongest diffracting crystals on beamlines at 
the Diamond Light Source (Harwell, UK) and the 
European Synchrotron Radiation Source 
(Grenoble, France) as detailed on Table 1. The 
data were processed and scaled in HKL2000 (52). 
As shown in Table 1, three crystal forms (A, B 
and C) of unliganded CodY were obtained with 
14, 10 and 2 molecules in the asymmetric unit 
respectively. 
The structure of the Form B unliganded CodY 
crystals was solved by molecular replacement 
initially using the structure of the unliganded GAF 
(coordinate set: 2GX5) domain as the search 
model. The initial molecular replacement solution 
of the latter had required pseudo-origin correction 
and gave an incentive to the development of the 
program Zanuda (53). Calculations in the program 
MOLREP (54) did not yield clear solutions owing 
to the large number of molecules in the 
asymmetric unit. The resulting models were 
therefore examined manually and prioritised on 
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the basis of whether they gave rise to GAF domain 
dimers reminiscent of that contained in the crystal 
structure of the search model. Suitable solutions 
were identified and fixed and a subsequent search 
was carried out using the wHTH domain 
(coordinate set; 1B0L).  
The resulting structure was refined using 
REFMAC (55) with non-crystallographic 
symmetry restraints applied. This revealed 
electron density for thH µPLVVLQJ¶ UHVLGXHV ZKLFK
form connecting helices. These were built 
manually in Coot (56).  From the refined 
coordinates of this Form B crystal structure, a 
dimer was used in molecular replacement 
calculations to solve the Form A and Form C 
crystal structures. 
Later the structure of CodY(L3S)-Ile was 
solved similarly but using the coordinate set 2B18 
representing the GAF domain with bound 
isoleucine followed by refinement using 
REFMAC (55). Figures of the structures of CodY 
were made using CCP4MG (57). The coordinates 
and structure factors for the models reported in 
this work have been deposited in the protein data 
bank with PDBIDs 5LOO, 5LNH and 5LOJ for 
the unliganded CodY crystal forms with 16, 10 
and 2 molecules per asymmetric unit respectively 
and 5LOE for CodY(L3S) in complex with 
isoleucine. 
Annealing DNA oligonucleotides ± 
Oligonucleotides, purified by HPLC, were 
purchased from Eurofins MWG Operon. 
Complementary oligonucleotides were 
resuspended in deionised water and incubated at a 
1:1 molar ratio at a concentration of 50 PM in a 
buffer composed of 25 mM Tris pH 8.5, 200 mM 
NaCl, 1 mM DTT and 0.5 mM EDTA. The 
ROLJRQXFOHRWLGHV ZHUH KHDWHG WR Û& IRU 
minutes to ensure full denaturation, followed by 
slow cooling to room temperature.  
Labelling of DNA fragments - The 
BcaPp8(19), BcaPp8(31) and BcaPp18(31) DNA 
duplexes were generated by annealing 
corresponding pairs of oligonucleotides (Table 3); 
the oligonucleotide mixtures in 10 mM Tris-Cl 
(7.5) - 50 mM KCl were heated for 5 min in a 
boiling water bath and allowed to cool to room 
temperature. The BcaPp8(36) DNA duplex was 
synthesized by PCR using oligonucleotides 
oBB466 and oBB460 as primers and pBB1622 as 
template. In each case, one of the oligonucleotides 
was pre-labeled using T4 polynucleotide kinase 
and [J-32P]-ATP.  
Gel shift experiments - Incubation of 
CodY with the 
32
P-labelled DNA duplexes was 
performed in 20 mM Tris-Cl (pH 8.0), 50 mM 
KCl, 2 mM MgCl2, 5% glycerol, 0.5 mM EDTA, 
1 mM DTT, 0.05% Nonidet P, 40-25 µg/ml 
salmon sperm DNA as a binding buffer. Samples 
(10 µl) containing varying amounts of CodY and 
less than 1 fmole of DNA were incubated for 16 
min at room temperature and separated on 8% 
non-denaturing 50 mM Tris, 384 mM glycine, 1 
mM EDTA polyacrylamide gels in 35 mM 
HEPES, 43 mM imidazole buffer. In some 
experiments, 10 mM ILV was added to the 
incubation mixture, gel, and electrophoresis 
buffer. The gels were dried, and the radioactive 
bands were detected and quantified using storage 
screens, PhosphorImager, and the ImageQuant 
software (GE Healthcare).  
SEC-MALLS - A Wyatt Dawn HELEOS-
II 18-angle light scattering detector and Wyatt 
Optilab rEX refractive index monitor linked to a 
Shimadzu HPLC system and SPD20A UV/Vis 
detector was used for SEC-MALLS. A Superdex 
S200 HR 10/30 size exclusion column was 
attached to the HPLC and equilibrated in a 
running buffer consisting of 50 mM TrisHCl pH 
7.5, 150 mM NaCl in the presence or absence of 
10 mM isoleucine. An SIL-20A Autosampler was 
XVHG WR LQMHFWȝO VDPSOHVRIPJPO-1 CodY 
samples, 19 µM DNA or mixtures of the two. Data 
were analysed with Astra software using a dn/dc 
value of 0.186 for protein and protein-DNA 
complexes and 0.168 for DNA (58,59) 
 Introduction of the codY(L3S) mutation 
in the B. subtilis chromosome -A PCR fragment 
containing the full-length codY (L3S) gene and 
the flanking sequences was synthesized by two-
step overlapping PCR. In the first step, the PCR 
SURGXFW FRQWDLQLQJ WKH ¶-part of the codY gene 
was synthesized by using oligonucleotide 
oBB594 as the forward primer and mutagenic 
oligonucleotide oBB596 as the reverse primer. In 
a similar manner, the PCR product containing the 
¶-part of the codY gene was synthesized by 
using mutagenic oligonucleotide oBB597 as the 
forward primer and oligonucleotides oBB595 as 
the reverse primer. The PCR products were used 
in a second, splicing step of PCR mutagenesis as 
overlapping templates to generate modified 
fragments containing the entire codY region; 
oligonucleotides oBB594 and oBB595 served as 
the forward and reverse PCR primers, 
respectively.  
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 The spliced PCR product was digested 
with XbaI and XhoI and cloned in an integrative 
plasmid pBB1579 (bgaB neo)(60), creating 
pBB1756 [codY(L3S) bgaB neo]. The latter 
plasmid was introduced by a single-crossover, 
homologous recombination event into the bcaP 
chromosomal locus of strain SMY. White Neos 
colonies indicating excision of pBB1756 from 
the chromosome were searched for on plates 
containing X-Gal (5-bromo-4-chloro-3-indolyl-ȕ-
D-galactopyranoside), the coloured substrate of 
bgaB-encoded E-galactosidase. Multiple colonies 
were tested for acquisition of the codY(L3S) 
mutation by sequencing PCR products from the 
chromosomal codY allele. 
Enzyme assays - E-Galactosidase 
activity was determined as described previously 
(61).  
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FIGURE LEGENDS 
FIGURE 1. The domain structure of CodY and the ligand binding site. Ribbon renderings of single 
chains from the crystal structures of unliganded CodY (A) and the CodY(L3S)-isoleucine complex (B). 
The chains are colour ramped from the N-terminus (red) to the C-terminus (magenta) with the helix-turn-
helix motif of the wHTH domain also coloured in red. The isoleucine ligand is shown as van der Waals 
spheres coloured by atom type, carbon, grey; oxygen, red; nitrogen blue. The GAF and wHTH domains 
are labelled. The sequence of the glutamate-rich central domain is also highlighted. (C) Stereo 
representation of the unliganded CodY structure with the secondary structure elements labelled. (D) and 
(E), Stereo views of the ligand binding pocket. In (D), residues surrounding the isoleucine effector are 
shown with polar protein-ligand interactions represented by dashed lines. The carbon atoms of the protein 
are shown in light blue and sulphur atoms are yellow. In (E), the GAF domains of unliganded CodY and 
the isoleucine liganded protein are superimposed and shown as white ribbons with the loops connecting 
E2 and E3, and E3 and E4 coloured in gold and blue respectively. The side chains of T96, F98 and R61 
are labelled in normal font in the unliganded domain and italics for the isoleucine complex so as to 
illustrate the extent of the conformational changes that accompany ligand binding. 
FIGURE 2. The tetrameric structures of CodY in the crystal. The four chains that form an obvious 
tetramer are shown in ribbon representation and with chains A, B, C and D coloured magenta, light blue, 
cyan and coral respectively. (A). The unliganded CodY is shown in two approximately orthogonal 
orientations following rotation about a vertical axis. The two pairs of GAF domains flanking the four 
central wHTH domains are evident. (B). The isoleucine liganded CodY(L3S) represented as above. The 
amino acid effector bound to each of the four GAF domains is shown as van der Waals spheres coloured 
by atom type, carbon, green; oxygen, red; nitrogen blue. (C) Modelled DNA complex of the unliganded 
CodY tetramer observed in the crystal, illustrating the steric clash between the DNA duplex and the distal 
pair of GAF domains. The duplex DNA is shown as a ribbon backbone (green) and the nucleic acid atoms 
are shown in ball-and-stick and coloured by atom type. The DNA molecule has been juxtaposed with the 
CodY protomers using rigid body superposition methods so that the HTH (coloured red) and wing 
elements of the wHTH domains in the proposed AB dimer fit into the major and minor groove of DNA as 
observed in the structure of the FadR-DNA complex (PDB code 1h9t). In these orthogonal views it is 
evident that the GAF domains from chains C and D clash sterically with the DNA. 
FIGURE 3. The quaternary structure of CodY. (A). Molecular mass measured from SEC-MALLS 
analysis. 100 Pl of 1 mg.ml-1 protein samples were loaded onto a Superdex S200 10/300 gel filtration 
column. The continuous thin lines trace the refractive index of the eluate from this column as a function 
of time. The short thicker lines represent the weight average molecular weight of the species in the eluate 
calculated using the light-scattering measurements. The black lines show the data from the experiment 
with wild type CodY while the orange lines show the data for CodY(L3S). (B). The GAF domain 
interface of chains A and B in the dimer. The contributions of the pair of Leu3 residues (side chains 
shown as cylinders) to the local hydrophobic core, through interactions with Leu4, Ile141 and Leu142 
residues (side chains shown as ball-and-stick), are evident. (C). Possible dimers arising from the CodY 
tetramer. The unliganded CodY tetramer, coloured by chain, is shown on the left with the three possible 
dimers AB, AC and AD shown moving from left to right.  
FIGURE 4. Structural changes in the CodY dimer upon ligand binding. (A) Stereo view of the 
unliganded CodY dimer (gold) and the isoleucine liganded CodY(L3S) dimer (blue) following 
superposition of the CD atoms from their GAF domains. The isoleucine ligand is shown as van der Waals 
spheres coloured by element.  (B) The long interdomain helices following superposition of the unliganded 
CodY dimer (gold) and the isoleucine liganded CodY(L3S) (blue) as in (A). These are shown for a single 
subunit (left) where the changing course of this D-helix is observed, and for the dimer (right) where the 
splaying of the pair of helices can be seen. (C) and (D) The overall structures of the liganded CodY(L3S) 
with chains coloured blue in (C) and unliganded CodY with chains coloured gold in (D). The orientation 
of the dimers in (C) and (D) is approximately orthogonal to that in (A). The splaying of the long helices 
and the increased separation of the wHTH domains accompanying isoleucine binding can be seen. 
Residues 203-240 spanning the helix-turn helix and the associated wing, consisting of a loop and flanking 
E-strands, are shown in red. 
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FIGURE 5. Gel-electrophoretic mobility shift assay of CodY binding to bcaP promoter fragments. 
Labeled BcaPp8(19) (A) and (B), BcaPp8(31) (C) and (D) and BcaPp8(36) (E) and (F) were incubated 
with increasing amounts of purified CodY in the presence (A), (C) and (E) or absence (B), (D) and (E) of 
10 mM isoleucine/leucine/valine. The CodY concentrations used (nanomolar of monomer) are indicated 
below each lane. The underlined values indicate the concentration of CodY needed to shift 50 % of the 
DNA fragments (under conditions of vast CodY molar excess). The arrows indicate the complexes C1 
and C2 described in the text.  (G) Assay of CodY binding to the BcaPp18(31) duplex containing multiple 
mutations in one of the putative CodY binding subsites  
FIGURE 6. Gel-electrophoretic mobility shift assay of CodY(L3S) binding to bcaP promoter fragments. 
Labeled BcaPp8(19) (A) and (B) and BcaPp8(36) (C) and (D) were incubated with increasing amounts of 
purified CodY(L3S) in the presence (A) and (C) or absence (B) and (D) of 10 mM 
isoleucine/leucine/valine. The CodY concentrations used (nanomolar of monomer) are indicated below 
each lane. The underlined values indicate the concentration of CodY needed to shift 50 % of the DNA 
fragments (under conditions of vast CodY molar excess). The arrows indicate the complexes C1 and C2 
described in the text.   
FIGURE 7. DNA binding analysed by SEC-MALLS. 100 Pl samples of 1 mg.ml-1 CodY incubated in the 
presence and absence of a molar equivalent of the BcaP36 oligonucleotide duplex (19 PM), and in the 
presence (A) and absence (B) of isoleucine (10 mM), were loaded onto a Superdex S200 10/300 gel 
filtration column. The continuous lines trace the refractive index of the eluate from this column as a 
function of time. The thick shorter lines represent the weight average molecular weight of the species in 
the eluate calculated using the light-scattering measurements. The black lines show the data from the 
experiments with CodY alone, the blue lines show the traces for the BcaP36 oligonucleotide duplex 
alone. The red lines show the data from the experiment in which CodY and BcaP36 were pre-incubated 
together in the presence (A) and absence (B) of isoleucine respectively. For the experiments in which 
isoleucine was present, the amino acid was also included in the column equilibration and running buffer. 
FIGURE 8. Models for CodY Action. (A) Model for CodY binding to bcaP promoter DNA fragments in 
the EMSA experiments. The model shows complexes with CodY protomer : DNA duplex stoichiometries 
of 2 : 1 and 4 : 1. The thickness of the arrows indicates the direction of the equilibrium. In this model, 
splaying is needed for DNA binding and the proportion of dimers in the splayed state is controlled by the 
BCAA, isoleucine (Ile). The splayed conformation in this schematic may or may not correspond to that in 
the crystal structure of CodY(L3S)-Ile. The dashed lines indicate non-covalent interactions between a pair 
of CodY dimers bound to DNA that would give rise to cooperative binding of a pair of CodY dimers to 
DNA. (B) Model of ligand-dependent activation in CodY in which non-covalent interactions between the 
wHTH and GAF domains within each protomer of an unliganded CodY dimer are disrupted upon 
isoleucine binding. (C) Structural model for the CodY4-DNA complex in which each CodY chain is 
shown as a ribbon and coloured by dimer. The two CodY dimers are shown bound to opposite faces of 
WKH'1$GXSOH[ZLWKµLQWHUGLJLWDWLRQ¶RIWKHZ+7+HOHPHQWVIURPHDFKGLPHU 
FIGURE 9. Comparison of homodimeric wHTH repressors with CodY. The QsrR-DNA complex (A) 
with subunits coloured in different shades of green (35), the FadR-DNA complex (36) (B) with subunits 
coloured ice blue and light blue and the IscR-DNA (37) (C) complex with chains coloured cyan and 
white. In each image the recognition helices are coloured in red. (D) Stereo image showing the 
superimposed wHTH domains from the A chains of QsrR (bright green), FadR (ice blue), IscR (cyan), 
unliganded CodY (light green) and CodY(L3S)-Ile (gold) in the context of the IscR operator DNA. As 
before the recognition helix of the A subunit is coloured in red. The recognition helix from the partner 
subunit is shown coloured according to structure as before. The differences in the juxtaposition of the pair 
of recognition helices in the various dimers are apparent. 
 
Table 1.  X-ray Data Collection and Refinement Statistics. 
Ligand/Molecules per AU 
CodY (Form A) 
-/14 
CodY (Form B) 
-/10 
CodY (Form C) 
-/2 
CodY(L3S) 
Ile/4 
Protein Data Bank ID 5LOO 5LNH 5LOJ 5LOE 
 
Data collection 
    
X-ray source SRS beamline PX14.1 SRS beamline PX14.2 ESRF beamline bm14 SRS beamline PX10.1 
 Wavelength () 0.98040 0.97820 0.93300 0.98000 
Collection Temperature (K) 100 100 100 100 
Resolution range () 20.00 - 4.60 50.00 - 3.00 25.00 - 3.70 50.00 - 3.00 
Space group C121 C121 P4322 P21212 
Unit-cell parameters (,¡) a = 315.63, b = 113.68, c = 168.59 
α = 90.0, β = 113.23, γ = 90.0 
a= 138.87, b = 110.55, c = 257.41 
α = 90.0, β =91.3, γ = 90.0 
a= 111.52, b = 111.52, c = 119.54 
α = 90.0, β =90.0, γ = 90.0 
a= 134.69, b = 158.88, c = 55.412 
α = 90.0, β =90.0, γ = 90.0 
Matthews coefficient/solvent content (%) 2.9 / 57.8 3.3 / 62.9 3.2 / 60.5 2.5 / 50.5 
Number of unique reflections, overall/outer shella 2,967 / 1,922 57,358 / 1,376 8,235 / 813 22,830 / 1,151 
Completeness (%), overall/outer shella 73.6 / 71.6 72.0 / 17.4 97.5 / 98.2 92.5 / 47.3 
I /σ(I), overall/outer shella 6.8 / 10 18.3 / 0.51 33.1 / 5.6 25.3 / 1.03 
Rmerge
b (%), overall/outer shella 9.0 / 50.8 10.2 / - 5.9 / 40.8 6.5 / 65.4 
Refinement and model statistics     
R-factorc (R-freed) 0.251 (0.429) 0.230 (0.279) 0.233 (0.388) 0.238 (0.290) 
Reflections (working/free) 27,647 / 1,479 53,946 / 2,880 7,842 / 381 21,607 / 1,164 
Outer shell R-factorc (R-freed) 0.253 (0.299) 0.425 (0.439) 0.215 (0.418) 0.359 (0.389) 
Outer shell reflections (working/free)  2577 / 162 837 / 53 541 / 33 728 / 44 
Molecules/asymmetric unit 14 10 2 4 
Number of protein non hydrogen atoms 28,546 20,090 4,004 8,187 
R.m.s. deviation from targetf     
Bond lengths () 0.011 0.018 0.019 0.012 
Bond angles (¡) 1.441 1.607 1.157 1.298 
Average B-factor (2) 235.09 86.52 80.43 96.32 
Ramachandran plotg 73.1/17.6/9.4 95.5/3.7/0.8 71.7/17.2/11.1 93.6/4.5/1.9 
 
aThe outer shell corresponds to 4.58 Ð 4.50 , 3.11 Ð 3.00 , 3.83 Ð 3.70 , , 3.11 Ð 3.00 . 
bRmerge = ∑HKL∑I|II - <I> 	|/∑HKL∑I	<I>  where II is the intensity of the ith measurement of a reflection with indexes hkl and <I> 	is the STATISTICALLY WEIGHTED AVERAGE REFLECTION INTENSITY. 
c
R-factor = ∑||Fo| - |Fo||/∑|Fo| where Fo and Fc are the observed and calculated structure factor amplitudes, respectively.  
d
R-free is the R-factor calculated with 5 % of the reflections chosen at random and omitted from refinement.  
e
Outer shell for refinement corresponds to 4.611 Ð 4.500 , 3.078 Ð 3.000 , 3.800 Ð 3.706 , , 3.078 Ð 3.000 . 
f
Root-mean-square deviation of bond lengths and bond angles from ideal geometry. 
g
 Percentage of residues in preferred/allowed/outlier regions.  
Table 2. Transcriptional Fusion Data 
Strain	 	 Genotype	 β-galactosidase	activity		
Expression	of	the	bcaP-lacZ	fusion	in	TSS	+	16	aa	medium	
BB2505	 wt	 0.15	
BB3663	 codY(L3S)	 14.2	
BB2548	 codY	 137.2	
Expression	of	the	ybgE-lacZ	fusion	in	TSS	+	16	aa	medium	
BB2770		 wt	 1.12	
BB3669	 codY(L3S)	 23.6	
BB2771	 codY	 	 428.0	
	
	 	
Table 3. Oligonucleotides used in DNA Binding  
DNA	(Source)	a	 Sequenceb	
BcaPp8(19)	(PbcaP	-56	to	-38)	
oBB459	
oBB460	
 
5Õ CGAATTTTCTGAAAATTTT  
5Õ AAAATTTTCAGAAAATTCG 
BcaPp18(31)		(PbcaP	-68	to	-38)	
oBB527	
oBB528	
 
5ÕgActgAcTgacTCGAATTTTCTGAAAATTTT 
5ÕAAAATTTTCAGAAAATTCGAgtcAgTcagTc 
BcaPp8(36)	(PbcaP	-73	to	-38)	
oVML12	
oVML13	
 
5Õ CAAAATAAAAAATTTGTCGAATTTTCTGAAAATTTT  
5Õ AAAATTTTCAGAAAATTCGACAAATTTTTTATTTTG 
BcaPp8(31)		(PbcaP	-68	to	-38)	
oBB463	
oBB464	
 
5Õ TAAAAAATTTGTCGAATTTTCTGAAAATTTT  
5Õ AAAATTTTCAGAAAATTCGACAAATTTTTTA 
a The primer pairs in each box are complementary oligonucleotides which were mixed to generate duplexes used in 
the DNA binding experiments.  
b Bold type in the sequence indicates the region with a match to the CodY consensus sequence. Underlining denotes 
a substitution in the sequence to match the consensus more closely. Lower case letters indicate positions at which 
the BcaPp18(31) duplex differs from the BcaPp8(31) duplex. 
	 	
Table 4. PCR oligonucleotide primers used in this work. 
	
	Primer	 Sequence	
oVML01 5Õ-CATGGCTAGCTTACAAAAAACAAGAATTATTAACTCCATG 
oVML02 5Õ-TTCTGCATCCTATTAATGAGATTTTAGATTTTCTAATTCAATTAGG 
oVLC01 5Õ-CCAGGGACCAGCAATGGCTTTATTACAAAAAACAAGAATTATTAACTC 
oVLC02 5Õ-GAGGAGAAGGCGCGTTAATGAGATTTTAGATTTTCTAATTCAATTAG 
oBB569 5Õ-AATTCGAGCTCAGGAGGATTATTTATCatggcttCattac 
oRPS33 5Õ-CCCCGCATGCTTAATGATGATGATGATGATGAGATTTTAGATTTTCT-
AATTCAATTAGG 
oBB460 5Õ-AAAATTTTCAGAAAATTcg 
oBB466 5Õ-CAAAATAAAAAATTTGTCG 
oBB594 5Õ-gcgtttcTAgattcgtgtagaactg 
oBB595 5Õ-TATTCctCgAGAATTAAGTCATCGTC 
oBB596 5Õ-TTTTGTAAgctAGCCATgataaataatc 
oBB597 5Õ-atttatcATGGCTagcTTACAAAAAACAAG 
 
 
	
Figure 1 
A GAF 
wHTH 
B 
156-167 
REKAEEIEEEAR 
B 
C 
D 
E 
Figure 1 
4 x wHTH 
2 x GAF 
2 x GAF 
B 
Unliganded 
Ile complex 
A 
Figure 2 
C 
C 
A 
B 
Figure 3 
(AB)  (AC)         (AD) 
B 
A 
Figure 4 
C D 
  0   0.4  0.8 1.6  3.1  6.3   13   25   50  100 
+ILV 
no ILV 
A 
C D 
B 
C1 
Figure 5 
BcaPp8(19) 
F E +ILV 
0    0.2  0.4  0.8  1.6  3.1  6.3 12.5  25  
50  
C2 
C1 
BcaPp8(31) 
0  3.1  6.3  13   25   50 100  200 400 800 
C2 
BcaPp8(31) 
 0    6.3  13   25   50  100  200 400 800 
1,600 
C1 
BcaPp8(19) no ILV 
+ILV 
+ILV 
CodY 
0   0.4   0.8  1.6 3.1   6.3 12.5 25  50  100 
BcaPp8(36) 
C2 
C1 
0   1.6   3.1  6.3  13   25   50 100 200 400  
C2 
BcaPp8(36) no ILV 
0    0.4  0.8   1.6  3.1  6.3   13   25    50  100 
G BcaPp18(31) +ILV 
C2 
C1 
Figure 6 
  0    0.8  1.6  3.1   6.3  12.5  25    50  100 200 
C 
C2 
BcaPp8(36) +ILV 
CodY(L3S) 
0   6.3  12.5   25  50   100  200  400 800 1,600 
A 
C1 
BcaPp8(19) +ILV 
0    6.3  12.5   25   50  100  200 400  800 1,600 
D 
C2 
BcaPp8(36) no ILV 
  0    6.3  12.5  25   50   100  200 400 800  1,600 
B no ILV BcaPp8(19) 
B 
A 
Figure 7 
Ile Ile Ile Ile Ile Ile 
Figure 8 
A 
bcaPp8(36) 
C2 
Ile Ile 
Ile Ile 
Ile Ile 
Ile 
Ile 
Ile Ile 
B 
Ile Ile 
C1 
C 
Figure 8 
D 
Figure 9 
B 
C A 
